Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases - EU-Startups
Breye Therapeutics is developing oral therapies for the early treatment of retinal diseases. This funding will advance their pipeline of novel treatments. The company aims to provide more accessible and convenient options for patients suffering from conditions like age-related macular degeneration and diabetic retinopathy.
Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases EU-Startups
| Oct 02, 2026 | Good Tape | $654K | — | Denmark |
| Sep 17, 2026 | BlueShadow | $2.0M | Pre-seed | Denmark |
| Sep 04, 2026 | ParlayX | $1.3M | Pre-seed | Denmark |
| Aug 26, 2026 | os.energy | $1.1M | Pre-seed | Denmark |
You just read who funded Breye Therapeutics. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.